Presentation of scholarships by Vītols Fund and Rigvir Group
September 2018
Read More
IVC organizes international Melanoma Awareness Days
July 2018
Read More
Virotherapy combined treatment – new paradigm in cancer treatment
May 2018
Read More
Rigvir Group becomes a biotech company
May 2018
Read More
Oncolytic virotherapy approved in Uzbekistan
April 2018
Read More
Rigvir Group company has recieved a €994,000 loan from EBRD and US private capital owned bank
December 2017
Read More
Vītols Foundation and Rigvir holding scholarships
September 2017
Read More
Rigvir Group receives “Seal of Exellence”
July 2017
Read More
WIPO Intellectual Property Award for Rigvir Group
April 2017
Read More
Discussion about oncolytic virotherapy in Latvian Academy of sciences
January 2017
Read More
Rigvir holding takes part in Central and Eastern Europe countries and China summit
November 2016
Read More
Participation in 24th World Cancer Congress 2016
November 2016
Read More
SME Instrument Innovators’ Summit 2016
October 2016
Read More
Melanoma screening campaign calls for preventive skin check-ups
September 2016
Read More
Horizon 2020 grant for cancer virotherapy medicine
July 2016
Read More
Oncolytic virotherapy approved in Armenia
May 2016
Read More
Opening of the Global Virotherapy Cancer Clinic
February 2016
Read More
Aina Muceniece Virotherapy Foundation established
February 2016
Read More
Rigvir holding announces a grant programme
January 2016
Read More
Agreement between Rigvir holding and charity foundation “Vītolu fonds”
January 2016
Read More
IV Virotherapy conference
November 2015
Read More
New clinical guidelines recommends oncolytic virotherapy
August 2015
Read More
Oncolytic virotherapy approved in Georgia
May 2015
Read More
Oncolytic virotherapy with RIGVIR® is reimbursable medication
2011
Read More
Opening of the International Viroterapy Center (IVC)
2008
Read More
State Agency of Medicines of the Republic of Latvia registers RIGVIR®
2004
Read More